Hayadan > Biotechnology in Israel

Biotechnology in Israel

Immunity Pharma announces the start of a clinical study in ALS patients with the original drug IPL344

Technology for accurate counting of bacterial colonies won the Merck hackathon in Israel

Messchallenge distributed prizes totaling about one million shekels to the winning companies in the first round of the acceleration program in Israel

University research vice presidents call for halting laws that would make animal testing impossible

Biotechnology Cluster: Maged Bio-Negev was officially inaugurated with six companies; 11 patents for Nixoa, LapSpace and Neuroderm recruit chicken-feeding robot

Biotechnology cluster: Levitas Cardio recruits; And also on: Protlix, Yes Fit, Redhill Biopharma, Compugen and a joint venture with Germany in the field of biotechnology

There is a very narrow window of opportunity for business between Israel and China in the biotechnological, pharmaceutical and medical equipment aspects

Biotechnology Cluster: Pluristem received the approval of the US Registrar for a key patent of the company

International interest in the biomed industry and medical devices in Israel - large delegations from Germany and Italy participated in IATI-biomed

President Obama's personal adviser on scientific affairs, among the participants at the IATI Biomed 2013 conference

The International Conference on Personalized Medicine returns to be hosted in Israel

The Dutch investment fund BOM Capital is coming to Israel - looking for technology and biomed companies

Ahead of the Israestem conference: Israel should invest in the field of regenerative medicine and stem cells, in order to maintain its leadership against countries that have decided to promote the field

Dr. Yair Erez, economist at McKinsey London: The model of a patient coming to the doctor with symptoms will not last.

Polypid, a developer of products for the local release of drugs, raised $2.4 million in a third funding round

57% increase in the number of biotechnology companies

Biotech cluster: Clover begins a clinical trial, Ergo Medical expands

Doctors in Israel - publish a lot, are cited less

"The 21st century is the century of biotechnology"

Four Israeli projects in the field of life sciences will be funded in the amount of 3 million dollars

Compugen and Mark Sarono's venture capital fund are jointly establishing Neviah Genomics) a new company for the discovery and development of diagnostic markers

A new venture capital fund - Boril Israel is on its way to the biomed industry in Jerusalem

Make a high wave

15 delegations that include senior officials from the global life sciences industry will arrive in Israel for a week at Yomed as guests of the Ministry of Science and Technology

"Niche" survey ahead of Israel Biomed week 2012: an increase of about 20% in the demand for workers in the fields of chemistry in the biomed industry

IVC-KPMG survey ahead of Biomed Israel Week 2012: life sciences companies led recruitment in the first quarter of 2012 - over a quarter of the total recruitment in the market

Ahead of the "Biomed Israel 2012" week: Since the beginning of the year, the R&D Fund has approved grants totaling 174 million shillings for 118 projects in the life sciences

Neuroderm has successfully completed a phase 2 trial of a drug for dermal insertion intended for the treatment of Parkinson's disease

An important publication for Prof. Amos Korchin

Israeli collaboration between Medigus and Tower-Jazz has produced the world's smallest endoscopy camera

An official delegation from Boston will arrive at the Biomed events with over a billion dollars in their pockets to look for investments in Israel

The German Merc strengthens research cooperation with Israel: establishes a strategic fund to operate a biotech incubator in Israel

Nature-owned Macmillan Publishing acquired control of the Israeli BioData

The year of the biomed

Export Institute: About 14% increase in life sciences exports in the first quarter to about 1.7 billion dollars

Towards the Biomed conference: The Ohio principle wants Israeli biomed companies

The chief scientist's research committee approved projects in the field of life sciences amounting to NIS 120 million

The 'Personalized Medicine' conference is coming to Israel in about a month

Significant increases in demand for life sciences workers and managers, but it will take time to return to 2008 figures

IVC survey towards Biomed: the leaders of the recruitments - life sciences companies in the early stages

The groups that passed the early screening stage for the establishment of life sciences investment funds were announced

Technological innovations, senior guests and business at the center of ILSI-Biomed Israel Week 2010

Minister Sylvan Shalom at the Negev Conference 2010: The Bio-Negev project is launched - an international innovation center for the biotechnology and life sciences industry will be established in the Negev as a regional industrial "cluster"

Elite Bio Ventures will develop a drug for Duchenne muscular dystrophy

The Technion researchers built a platform for the confinement of transgenic stem cells that create an anti-cancer drug

Pluristem's stem cell technology was selected as one of the most important future innovations in Israel and will be presented at the President's Conference

Transpharma: Successful completion of phase 2 clinical trial of a system for percutaneous delivery of a drug for osteoporosis

The Office of the Chief Scientist at the Ministry of Defense and the Ministry of Finance announced the establishment of a government-backed biotechnology fund

The chief scientist: in 7 months we invested 480 m in the life sciences industry - a 50% increase compared to 2008

Orsens launches a system for continuous and non-invasive measurement of hemoglobin level and blood oxygen saturation